Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

LB Pharmaceuticals Inc Common Stock LBRX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
50/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$33.00
+13.3%

LBRX Insider Ownership

Top Holder
-
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value

No ownership data available for LBRX.

People Also View

DSGN
DSGN
Design Therapeutics, Inc.
$12.75
+0.87%
 ANNX
ANNX
Annexon, Inc.
$6.35
+9.48%
 SLDB
SLDB
Solid Biosciences Inc.
$8.32
+1.09%
 DBVT
DBVT
DBV Technologies S.A.
$21.25
-1.80%
 AURA
AURA
Aura Biosciences, Inc.
$7.09
+0.07%
 RCKT
RCKT
Rocket Pharmaceuticals, Inc.
$3.88
+6.59%
 LRMR
LRMR
Larimar Therapeutics, Inc.
$4.83
-0.82%
 AUTL
AUTL
Autolus Therapeutics plc
$1.49
+0.68%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message